Skip to main content
Erschienen in: Head and Neck Pathology 2/2014

01.06.2014 | Case Report

Extramedullary Plasmacytoma of the Trachea

verfasst von: Renu Sukumaran, Rekha A. Nair, Priya Mary Jacob, Sumod Mathew Koshy, Arun Peter Mathew

Erschienen in: Head and Neck Pathology | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

Extramedullary plasmacytomas are plasma cell tumors that occur outside the bone marrow. They constitute around 4 % of all plasma cell neoplasms. The most common site of extramedullary plasmacytoma is the upper aerodigestive tract—nasal cavity, paranasal sinuses and oronasopharynx. We are presenting a case of extramedullary plasmacytoma of the trachea. Trachea is an extremely rare site of plasmacytoma. When extraosseous plasmacytoma occur in uncommon sites, the distinction from B cell lymphomas showing extensive plasmacytic differentiation can be difficult and diagnostically challenging.
Literatur
1.
Zurück zum Zitat Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, editors. WHO classification of tumors of haematopoetic and lymphoid tissues. IARC: Lyon, France; 2008. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, editors. WHO classification of tumors of haematopoetic and lymphoid tissues. IARC: Lyon, France; 2008.
2.
Zurück zum Zitat Bachar G, Goldstein D, Brown D, Tsang R, Lockwood G, Perez-Ordonez B, Irish J. Solitary extramedullary plasmacytoma of the head and neck-long term outcome analysis of 68 cases. Head Neck. 2008;30:1012–9.PubMedCrossRef Bachar G, Goldstein D, Brown D, Tsang R, Lockwood G, Perez-Ordonez B, Irish J. Solitary extramedullary plasmacytoma of the head and neck-long term outcome analysis of 68 cases. Head Neck. 2008;30:1012–9.PubMedCrossRef
3.
Zurück zum Zitat Reyhan M, Rercan F, Ergin M, Sukan A, Aydin M, Yapar F. Sonographic diagnosis of a tracheal extramedullary plasmacytoma. J Ultrasound Med. 2005;24:1031–4.PubMed Reyhan M, Rercan F, Ergin M, Sukan A, Aydin M, Yapar F. Sonographic diagnosis of a tracheal extramedullary plasmacytoma. J Ultrasound Med. 2005;24:1031–4.PubMed
4.
Zurück zum Zitat Papadopoulou A, Froudarakis M, Abatzoglou I, Koukourakis MI. Tracheal cancer treated with a short course of external and endoluminal radio-chemotherapy combined with cetuximab—a case report. J Contemp Brachyther. 2010;2:160–2.CrossRef Papadopoulou A, Froudarakis M, Abatzoglou I, Koukourakis MI. Tracheal cancer treated with a short course of external and endoluminal radio-chemotherapy combined with cetuximab—a case report. J Contemp Brachyther. 2010;2:160–2.CrossRef
5.
Zurück zum Zitat Rai SP, Kumar R, Bharadwaj R, Panda BN. Solitary tracheal plasmacytoma. Indian J Chest Dis Allied Sci. 2003;45:269–72.PubMed Rai SP, Kumar R, Bharadwaj R, Panda BN. Solitary tracheal plasmacytoma. Indian J Chest Dis Allied Sci. 2003;45:269–72.PubMed
6.
Zurück zum Zitat Lomeo PE, McDonald JE, Finneman J. Shoreline. Extramedullary plasmacytoma of nasal sinus cavities. Am J Otolaryngol. 2007;28:50–1.PubMedCrossRef Lomeo PE, McDonald JE, Finneman J. Shoreline. Extramedullary plasmacytoma of nasal sinus cavities. Am J Otolaryngol. 2007;28:50–1.PubMedCrossRef
7.
Zurück zum Zitat Seegmiller AC, Xu Y, McKenna RW, Karandikar NJ. Immunophenotypic differentiation between neoplastic plasma cells in mature B cell lymphoma vs plasma cell myeloma. Am J Clin Pathol. 2007;127:176–81.PubMedCrossRef Seegmiller AC, Xu Y, McKenna RW, Karandikar NJ. Immunophenotypic differentiation between neoplastic plasma cells in mature B cell lymphoma vs plasma cell myeloma. Am J Clin Pathol. 2007;127:176–81.PubMedCrossRef
8.
Zurück zum Zitat Ely SA, Knowles DM. Expression of CD56/neural cell adhesion molecule correlates with the presence of lytic bone lesions in multiple myeloma and distinguishes myeloma from monoclonal gammopathy of undetermined significance and lymphomas with plasmacytoid differentiation. Am J Pathol. 2002;160:1293–9.PubMedCentralPubMedCrossRef Ely SA, Knowles DM. Expression of CD56/neural cell adhesion molecule correlates with the presence of lytic bone lesions in multiple myeloma and distinguishes myeloma from monoclonal gammopathy of undetermined significance and lymphomas with plasmacytoid differentiation. Am J Pathol. 2002;160:1293–9.PubMedCentralPubMedCrossRef
9.
Zurück zum Zitat Van Camp B, Durie BG, Spier C, De Waele M, Van Riet I, Vela E, et al. Plasma cells in multiple myeloma express a natural killer cell-associated antigen:cD56 (NKH_1;Leu-19). Blood. 1990;76:377–82.PubMed Van Camp B, Durie BG, Spier C, De Waele M, Van Riet I, Vela E, et al. Plasma cells in multiple myeloma express a natural killer cell-associated antigen:cD56 (NKH_1;Leu-19). Blood. 1990;76:377–82.PubMed
10.
Zurück zum Zitat Kremer M, Ott G, Nathrath M, Specht K, Stecker K, Alexiou C, et al. Primary extramedullary plasmacytoma and multiple myeloma: phenotypic differences revealed by immunohistochemical analysis. J Pathol. 2005;205:92–101.PubMedCrossRef Kremer M, Ott G, Nathrath M, Specht K, Stecker K, Alexiou C, et al. Primary extramedullary plasmacytoma and multiple myeloma: phenotypic differences revealed by immunohistochemical analysis. J Pathol. 2005;205:92–101.PubMedCrossRef
11.
Zurück zum Zitat Hussong JW, Perkins SL, Schnitzer B, Hargreaves H, Frizzera G. Extramedullary plasmacytoma : a form of marginal zone lymphoma ? Am J Clin Pathol. 1999;111:111–6.PubMed Hussong JW, Perkins SL, Schnitzer B, Hargreaves H, Frizzera G. Extramedullary plasmacytoma : a form of marginal zone lymphoma ? Am J Clin Pathol. 1999;111:111–6.PubMed
12.
Zurück zum Zitat Bink K, Haralambieva E, Kremer M, Ott G, Beham-Schmid C, de Leval L, et al. Primary extramedullary plasmacytoma: similarities with and differences from multiple myeloma revealed by interphase cytogenetics. Heamatologica. 2008;93:623–6.CrossRef Bink K, Haralambieva E, Kremer M, Ott G, Beham-Schmid C, de Leval L, et al. Primary extramedullary plasmacytoma: similarities with and differences from multiple myeloma revealed by interphase cytogenetics. Heamatologica. 2008;93:623–6.CrossRef
13.
Zurück zum Zitat Dimopoulos MA, Hamilos G. Solitary bone plasmacytoma and extramedullary plasmacytoma. Curr Treat Options Oncol. 2002;3:255–9.PubMedCrossRef Dimopoulos MA, Hamilos G. Solitary bone plasmacytoma and extramedullary plasmacytoma. Curr Treat Options Oncol. 2002;3:255–9.PubMedCrossRef
14.
Zurück zum Zitat Alexiou C, Kau RJ, Dietzfelbinger H, Kremer M, Spiess JC, Schratzenstaller B, et al. Extramedullary plasmacytoma: tumor occurrence and therapeutic concepts. Cancer. 1999;85:2305–14.PubMedCrossRef Alexiou C, Kau RJ, Dietzfelbinger H, Kremer M, Spiess JC, Schratzenstaller B, et al. Extramedullary plasmacytoma: tumor occurrence and therapeutic concepts. Cancer. 1999;85:2305–14.PubMedCrossRef
Metadaten
Titel
Extramedullary Plasmacytoma of the Trachea
verfasst von
Renu Sukumaran
Rekha A. Nair
Priya Mary Jacob
Sumod Mathew Koshy
Arun Peter Mathew
Publikationsdatum
01.06.2014
Verlag
Springer US
Erschienen in
Head and Neck Pathology / Ausgabe 2/2014
Elektronische ISSN: 1936-0568
DOI
https://doi.org/10.1007/s12105-013-0491-7

Weitere Artikel der Ausgabe 2/2014

Head and Neck Pathology 2/2014 Zur Ausgabe

Sine qua non Clinicopathologic Correlat

Cherubism

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …